Analysts See $0.08 EPS for MidSouth Bancorp, Inc. (MSL); Pentwater Capital Management LP Has Upped Esperion Therapeutics (ESPR) Holding

January 10, 2018 - By Michael Collier

Pentwater Capital Management Lp increased Esperion Therapeutics Inc (ESPR) stake by 12.84% reported in 2017Q3 SEC filing. Pentwater Capital Management Lp acquired 255,200 shares as Esperion Therapeutics Inc (ESPR)’s stock rose 33.24%. The Pentwater Capital Management Lp holds 2.24 million shares with $112.43M value, up from 1.99 million last quarter. Esperion Therapeutics Inc now has $1.73 billion valuation. The stock decreased 2.22% or $1.5 during the last trading session, reaching $66.17. About 390,129 shares traded. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 133.75% since January 10, 2017 and is uptrending. It has outperformed by 117.05% the S&P500.

Analysts expect MidSouth Bancorp, Inc. (NYSE:MSL) to report $0.08 EPS on January, 30.They anticipate $0.04 EPS change or 33.33% from last quarter’s $0.12 EPS. MSL’s profit would be $1.32 million giving it 45.00 P/E if the $0.08 EPS is correct. After having $0.07 EPS previously, MidSouth Bancorp, Inc.’s analysts see 14.29% EPS growth. The stock increased 0.35% or $0.05 during the last trading session, reaching $14.4. About 21,178 shares traded. MidSouth Bancorp, Inc. (NYSE:MSL) has risen 37.43% since January 10, 2017 and is uptrending. It has outperformed by 20.73% the S&P500.

Investors sentiment increased to 1.67 in 2017 Q3. Its up 0.45, from 1.22 in 2017Q2. It improved, as 11 investors sold ESPR shares while 34 reduced holdings. 30 funds opened positions while 45 raised stakes. 22.73 million shares or 17.55% more from 19.33 million shares in 2017Q2 were reported. J Goldman Limited Partnership reported 30,020 shares stake. Prelude Cap Mngmt Ltd Limited Liability Company has invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Stifel Fincl reported 0% stake. Meditor Limited stated it has 17.46% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Gam Holding Ag holds 0.48% in Esperion Therapeutics, Inc. (NASDAQ:ESPR) or 225,000 shares. The California-based Partner Inv Mngmt Lp has invested 0.43% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Lord Abbett Ltd Company holds 235,889 shares. Citigroup owns 28,552 shares. Proshare Advsrs Lc reported 0.01% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). State Bank Of New York Mellon holds 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 115,372 shares. Iguana Healthcare Mgmt Ltd Liability Corporation stated it has 4.2% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Nationwide Fund reported 0% stake. Ameriprise stated it has 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Deutsche Bancorp Ag owns 117,987 shares. Caisse De Depot Et Placement Du Quebec holds 0.03% or 250,000 shares.

Pentwater Capital Management Lp decreased Silverbow Res Inc stake by 36,081 shares to 541,668 valued at $13.30 million in 2017Q3. It also reduced Videocon D2h Ltd stake by 257,194 shares and now owns 42,701 shares. Kinder Morgan Inc (NYSE:KMI) was reduced too.

Among 18 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. Esperion Therapeutics had 50 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Underperform” rating given on Wednesday, June 29 by Credit Suisse. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) has “Buy” rating given on Tuesday, October 3 by Northland Capital. Cowen & Co maintained the stock with “Buy” rating in Wednesday, October 18 report. Needham upgraded Esperion Therapeutics, Inc. (NASDAQ:ESPR) on Monday, August 10 to “Buy” rating. Citigroup maintained it with “Buy” rating and $22 target in Wednesday, June 29 report. Needham upgraded the shares of ESPR in report on Thursday, December 14 to “Buy” rating. The firm has “Market Outperform” rating by JMP Securities given on Wednesday, March 9. As per Wednesday, August 9, the company rating was maintained by Deutsche Bank. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) earned “Hold” rating by Zacks on Friday, September 4. The firm earned “Strong Buy” rating on Wednesday, August 19 by Needham.

Among 6 analysts covering MidSouth Bancorp (NYSE:MSL), 3 have Buy rating, 1 Sell and 2 Hold. Therefore 50% are positive. MidSouth Bancorp had 16 analyst reports since September 22, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained the stock with “Hold” rating in Tuesday, October 3 report. Stephens maintained the shares of MSL in report on Friday, April 28 with “Hold” rating. Raymond James downgraded the shares of MSL in report on Friday, June 9 to “Underperform” rating. The stock of MidSouth Bancorp, Inc. (NYSE:MSL) earned “Buy” rating by Stephens on Tuesday, August 1. The rating was maintained by Stephens with “Buy” on Monday, June 12. The firm has “Hold” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The company was upgraded on Monday, February 6 by Hovde Group. The stock of MidSouth Bancorp, Inc. (NYSE:MSL) has “Strong Buy” rating given on Monday, May 9 by Raymond James. The stock of MidSouth Bancorp, Inc. (NYSE:MSL) has “Outperform” rating given on Tuesday, June 13 by Hovde Group. As per Friday, December 16, the company rating was downgraded by Raymond James.

Since October 27, 2017, it had 0 insider buys, and 2 selling transactions for $113,237 activity. CLOUTIER C R sold $1,370 worth of stock or 100 shares.

MidSouth Bancorp, Inc., a financial holding company, through its subsidiary MidSouth Bank, N.A., provides various community banking services and products to commercial and retail clients in the United States. The company has market cap of $238.30 million. The firm offers various deposit products, including interest-bearing money market and savings deposits accounts, interest-bearing and noninterest-bearing checking accounts, investment accounts, and NOW account deposits, as well as time deposits, such as certificates of deposits; and commercial and industrial, commercial real estate, and consumer loans, as well as other loans secured by real estate. It currently has negative earnings. It also provides cash management services; and electronic banking services comprising remote deposit capturing services, Internet banking, and debit and credit cards.

Investors sentiment decreased to 2.18 in Q3 2017. Its down 0.14, from 2.32 in 2017Q2. It turned negative, as 6 investors sold MidSouth Bancorp, Inc. shares while 11 reduced holdings. 6 funds opened positions while 31 raised stakes. 9.28 million shares or 10.37% more from 8.40 million shares in 2017Q2 were reported. Rhumbline Advisers stated it has 10,173 shares. Bank & Trust Of New York Mellon has 61,708 shares for 0% of their portfolio. Renaissance Techs Ltd accumulated 0% or 310,198 shares. Pacific Ridge Capital Partners Limited Liability has invested 0.8% in MidSouth Bancorp, Inc. (NYSE:MSL). Tiaa Cref Investment Mngmt Ltd invested in 24,606 shares or 0% of the stock. Tower Limited Liability Corp (Trc) invested in 0.01% or 5,529 shares. Blackrock reported 664,510 shares. Basswood Capital Ltd Llc holds 0.43% of its portfolio in MidSouth Bancorp, Inc. (NYSE:MSL) for 779,980 shares. Hotchkis And Wiley Mngmt Limited invested 0% of its portfolio in MidSouth Bancorp, Inc. (NYSE:MSL). Ulysses Mngmt Ltd Llc accumulated 202,102 shares. Panagora Asset Mgmt Inc has 349 shares. Naples Global Ltd Limited Liability Company reported 0.1% in MidSouth Bancorp, Inc. (NYSE:MSL). State Bank Of Montreal Can has 689 shares. State Common Retirement Fund owns 0% invested in MidSouth Bancorp, Inc. (NYSE:MSL) for 9,500 shares. Moreover, National Bank & Trust Of America De has 0% invested in MidSouth Bancorp, Inc. (NYSE:MSL) for 5,074 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts